In line with this, Zhao et al. revealed that the treatment of people with obesity with n-3 MUFAs, such as linolenic acid, decreases free plasma FAs, IL-6, and TNFα levels and increase PPARγ expression in mononuclear cells (PBMCs) [11,115]. Here, IL6 is linked to obesity disorder.